Department of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima City, Japan.
Department of Gastrointestinal Tract Surgery, Fukushima Medical University, Fukushima City, Japan.
Cancer Rep (Hoboken). 2024 Jun;7(6):e2099. doi: 10.1002/cnr2.2099.
An elevated neutrophil-to-lymphocyte ratio (NLR) in peripheral blood is an independent prognostic indicator of various cancers.
In this study, we aimed to investigate the prognostic relevance of the intratumoral immune cell balance in gastric cancer.
The study included 82 patients who underwent curative resection for gastric cancer. The intratumoral cluster of differentiation (CD) 15- and CD8-positive cells were evaluated using immunohistochemical staining. Additionally, clinicopathological factors and prognoses were analyzed. Patients with high intratumoral CD15/CD8 ratios had significantly lower overall survival (OS) and relapse-free survival (RFS) compared to those with low CD15/CD8 ratios (p = .0026 and p < .0001, respectively). Additionally, a high CD15/CD8 ratio was associated with lymph node metastasis (p = .019). Patients with high NLR had a significantly lower RFS than those with low NLR (p = .0050). Multivariate analysis revealed that the intratumoral CD15/CD8 ratio, NLR, and venous invasion were independent prognostic indicators of RFS (CD15/CD8 ratio: p < .001, hazard ratio (HR) = 14.7, 95% confidence interval (CI) = 3.8-56.8; NLR: p = .010, HR = 5.4, 95% CI = 1.5-19.6; venous invasion: p = .005, HR = 7.4, 95% CI = 1.8-29.7).
In summary, we found that the intratumoral CD15/CD8 ratio is an independent prognostic factor following gastric cancer resection and its increase is associated with lymph node metastasis and microscopic lymph vessel invasion. Immunological evaluation with additional aspects of innate immunity may be useful in predicting cancer prognosis.
外周血中性粒细胞与淋巴细胞比值(NLR)升高是各种癌症的独立预后指标。
本研究旨在探讨胃癌肿瘤内免疫细胞平衡的预后相关性。
本研究纳入了 82 例行胃癌根治术的患者。采用免疫组织化学染色评估肿瘤内 CD15 和 CD8 阳性细胞簇。此外,还分析了临床病理因素和预后。肿瘤内 CD15/CD8 比值高的患者总生存(OS)和无复发生存(RFS)显著低于 CD15/CD8 比值低的患者(p=0.0026 和 p<0.0001)。此外,高 CD15/CD8 比值与淋巴结转移相关(p=0.019)。NLR 高的患者 RFS 显著低于 NLR 低的患者(p=0.0050)。多因素分析显示,肿瘤内 CD15/CD8 比值、NLR 和静脉侵犯是 RFS 的独立预后因素(CD15/CD8 比值:p<0.001,HR=14.7,95%CI=3.8-56.8;NLR:p=0.010,HR=5.4,95%CI=1.5-19.6;静脉侵犯:p=0.005,HR=7.4,95%CI=1.8-29.7)。
总之,我们发现肿瘤内 CD15/CD8 比值是胃癌切除术后的独立预后因素,其升高与淋巴结转移和微观淋巴管侵犯有关。通过评估肿瘤内免疫细胞平衡以及固有免疫的其他方面,可能有助于预测癌症的预后。